702 filings
Page 7 of 36
25-NSE
ohn 2h87dqiu
24 Jun 19
Exchange delisting
9:38am
8-K
ichy0
31 May 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:00am
8-K
1ccru
15 Jan 19
Departure of Directors or Certain Officers
6:15am
8-K
h05i0a
29 Nov 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
0eg4ki2erba 77li
13 Aug 18
Submission of Matters to a Vote of Security Holders
5:29pm
8-K
e0efbn8gx0zgo
10 Aug 18
CytRx Corporation Reports Second Quarter 2018 Financial Results
4:30pm
DEFA14A
iis9fbsgsgtrn
19 Jul 18
Additional proxy soliciting materials
1:34pm
8-K
ie0if6s inyktwwa
22 Jun 18
Amendments to Articles of Incorporation or Bylaws
11:59am
8-K
t5w5i5
4 Jun 18
CytRx Corporation Launches Centurion BioPharma Corporation to Advance LADRâ„¢ Albumin Binding Ultra-High Potency Oncology Drug Candidates
12:00am
8-K
dei dxj2ajze
16 May 18
CytRx Announces $7.0 Million Registered Direct Offering
12:00am
424B5
lizflmtn
11 May 18
Prospectus supplement for primary offering
5:31pm
8-K
ru5wgb3z dkk73wfuny
8 May 18
CytRx Reports First Quarter 2018 Financial Results
1:32pm
8-K
asvf6o2d
7 May 18
CytRx Corporation Names Eric L. Curtis
5:24pm